• News
  • BioTech

U.S. Senators Say Valeant’s Allergan Bid Needs Regulator Review

June 26 (Bloomberg) -- Seven U.S. senators are asking federal regulators to review the potential impact of a hostile takeover by Valeant Pharmaceuticals International Inc. of California-based Allergan Inc., the maker of Botox.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!